XML 50 R37.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense

We recognize total stock-based compensation expense in our Consolidated Statements of Operations as follows (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

Cost of goods sold

 

$

1,946

 

 

$

3,177

 

Research and development

 

 

8,161

 

 

 

13,890

 

General and administrative

 

 

11,505

 

 

 

16,321

 

Total stock-based compensation

 

$

21,612

 

 

$

33,388

 

Schedule of Black-Scholes Option-Pricing Model Assumptions Used to Calculate Fair Value of Employee Stock Options

The following table lists the Black-Scholes option-pricing model assumptions used to calculate the fair value of employee and director stock options, as well as the resulting grant-date fair value:

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

Average risk-free interest rate

 

 

4.2

%

 

 

4.0

%

Dividend yield

 

 

0.0

%

 

 

0.0

%

Average volatility factor

 

 

91.7

%

 

 

88.4

%

Weighted-average expected life

 

5.1 years

 

 

5.1 years

 

Weighted-average grant-date fair value of options granted

 

$

0.76

 

 

$

0.37

 

Schedule of Stock Option Activity Under Equity Incentive Plans

The table below presents a summary of stock option activity under our equity incentive plans (in thousands, except for price per share and contractual life information):

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

Weighted-

 

 

Average

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

 

 

 

Number

 

 

Exercise

 

 

Contractual

 

 

Aggregate

 

 

of

 

 

Price

 

 

Life

 

 

Intrinsic

 

 

Shares

 

 

per Share

 

 

(in Years)

 

 

Value(1)

 

Outstanding at December 31, 2023

 

 

23,016

 

 

$

8.26

 

 

 

 

 

 

 

Options granted

 

 

12,541

 

 

 

1.04

 

 

 

 

 

 

 

Options exercised

 

 

(144

)

 

 

0.52

 

 

 

 

 

 

 

Options forfeited & canceled

 

 

(2,354

)

 

 

7.87

 

 

 

 

 

 

 

Outstanding at December 31, 2024

 

 

33,059

 

 

$

5.58

 

 

 

6.39

 

 

$

4,468

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at December 31, 2024

 

 

11,347

 

 

 

13.14

 

 

 

4.62

 

 

$

1,230

 

 

 

(1)
Aggregate intrinsic value represents the difference between the exercise price of the option and the closing market price of our common stock on December 31, 2024.
Schedule of Restricted Stock Unit Award Activity

A summary of RSU award activity is as follows (in thousands except for per share amounts):

 

 

 

 

 

Weighted-

 

 

 

 

 

Average

 

 

 

 

 

Grant

 

 

 

 

 

Date Fair

 

 

Units Issued

 

 

Value

 

Unvested at December 31, 2023

 

 

4,230

 

 

$

6.14

 

Granted

 

 

50

 

 

 

1.09

 

Vested and released

 

 

(2,474

)

 

 

5.82

 

Forfeited and canceled

 

 

(283

)

 

 

3.06

 

Unvested at December 31, 2024

 

 

1,523

 

 

$

7.07